Drug Company to Sell Hepatitis C Drug in India For $82,200 Less Per Regimen Than in the U.S.

September 17, 2014 at 2:55 PM Leave a comment

Yep, you read that title right:

Gilead logo via gilead.com

(Image via Gilead.com)

Sofosbuvir, the wonder medicine for Hepatitis C that costs $84,000 … for a 24-week treatment regimen in the US, will soon be available in India for about $1,800 … for the same regimen. The patent holder, pharma major Gilead, announced on Monday that it would be selling the drug at this price in India and also giving voluntary licences to seven Indian pharma companies to produce it.


This is outrageous and it’s where we need government regulation where there is none.  This is extortion thinly disguised as capitalism but also looking a whole lot like raw greed.


Entry filed under: Corporatocracy, Health - Physical and Psychological.

Republicans Behaving a Little Like ISIS The Ever-Shrinking British Empire

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


%d bloggers like this: